-
Uncategorized
Agora Holdings Inc. Subsidiary, eSilkroad Network Limited, Retains Kitsoft to Improve Functionality of eSilknet Platform
Disclaimer :This is a paid advertisement and all individuals should verify all claims and perform their own due diligence on…
Read More » -
Business
22nd Century Group Inc (NYSEMKT:XXII) Announced Expiry of Crede Warrants
22nd Century Group Inc (NYSEMKT:XXII) shares were down 7.79% on Wednesday to $1.42 and flat in after-hours trading. Share prices…
Read More » -
Business
IAMGOLD Corp (USA) (NYSE:IAG) Soars on Gold’s Gains
At market open on Tuesday in the US, Toronto based IAMGOLD Corp (USA) (NYSE:IAG) could be had for a little…
Read More » -
Business
(OTCMKTS:ADRNY) ADRNY Ahold NV Goes Green
(OTCMKTS:ADRNY) Ahold NV Goes Green on Massive Volume Shares of (OTCMKTS:ADRNY) Ahold NV traded green with massive volume brought on…
Read More » -
Business
1globe Capital Llc. Picked Up Exelixis Inc. (NASDAQ:EXEL) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Exelixis Inc. (NASDAQ:EXEL) reported that…
Read More » -
Business
1PM Industries Inc (OTCMKTS:OPMZ) Investors Cheer New Business Model
1PM Industries Inc (OTCMKTS:OPMZ) shares were up 12% on Wednesday to $0.00280 and unchanged in after-hours trading. Share prices have…
Read More » -
News
4 Beginner Tips for Successful Day Trading
[ad_1] Image by way of Flickr by rednuht Day buying and selling is usually a harmful sport for those that…
Read More » -
Biotech
Advaxis Inc (NASDAQ:ADXS) Forms Global Agreement with Amgen
Advaxis Inc (NASDAQ:ADXS) shares were up 6.24% on Monday and down 0.99% in after-hours trading after announcing its global agreement…
Read More » -
Biotech
Aeglea Bio Therapeutics Inc (NASDAQ:AGLE) Set to Gain on Lead Candidate Data Presentation
Aeglea Bio Therapeutics Inc (NASDAQ:AGLE), a Texas based development stage biotech company, just gave us an update regarding its intentions…
Read More » -
Uncategorized
MediciNova, Inc. (NASDAQ:MNOV) Gains on Positive MN-166 Interim
Premarket on Wednesday, April 20, 2016, development stage biotech company MediciNova, Inc. (NASDAQ:MNOV) reported interim data from its ongoing trial…
Read More »
